You are here:

tigecycline 50mg vial of powder tigecycline for intravenous infusion (Tygacil)

Advice

Following a full submission.

Tigecycline (Tygacil) is accepted for restricted use within NHS Scotland for the treatment of complicated skin and soft-tissue infections.

Tigecycline is associated with clinical cure rates in patients with complicated skin and skin structure infections non-inferior to those with a combination of a glycopeptide and a monocyclic beta-lactam antibiotic.

It is restricted to use as a 2nd or 3rd line agent under the advice of local microbiologists or specialists in infectious diseases.

Drug Details

Drug Name: tigecycline 50mg vial of powder tigecycline for intravenous infusion (Tygacil)
SMC Drug ID: 276/06
Manufacturer: Wyeth Pharmaceuticals
Indication: Complicated skin and soft-tissue infections
BNF Category:
Submission Type: Full submission
Status: Restricted
Date Advice Published: 10 July 2006

Back